Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -22.60% is 381% below its 5-year average of 8.05%, near the low end of its 5-year range (-33.44%–12.51%).
As of the fiscal period ended Tuesday, June 30, 2026. 8.79% below its 12-month average of -20.77%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation.
RETURN ON EQUITY (ROE)
-22.60%
RETURN ON EQUITY (ROE) AVG TTM
-20.77%
RETURN ON EQUITY (ROE) AVG 3Y
-1.28%
RETURN ON EQUITY (ROE) AVG 5Y
8.05%
RETURN ON EQUITY (ROE) AVG 10Y
8.80%
RETURN ON EQUITY (ROE) AVG 15Y
9.41%
RETURN ON EQUITY (ROE) AVG 20Y
10.25%
CURRENT VS TTM AVG
-8.79%
CURRENT VS 3Y AVG
-1669.60%
CURRENT VS 5Y AVG
-380.87%
CURRENT VS 10Y AVG
-356.86%
CURRENT VS 15Y AVG
-340.08%
CURRENT VS 20Y AVG
-320.40%
SECTOR MEDIAN · HEALTHCARE
13.01%
median of 84 covered companies
CURRENT VS SECTOR MEDIAN
-273.71%
vs the sector median at left
Centene Corp.
Market Cap
$31.77B
Return on Equity (ROE)
-22.60%
TTM Avg
-20.77%
3Y Avg
-1.28%
5Y Avg
8.05%
Market Cap
$31.88B
Return on Equity (ROE)
38.14%
TTM Avg
28.93%
3Y Avg
25.01%
5Y Avg
22.95%
Market Cap
$31.91B
Return on Equity (ROE)
23.13%
TTM Avg
23.30%
3Y Avg
22.33%
5Y Avg
21.49%
Market Cap
$31.54B
Return on Equity (ROE)
4.43%
TTM Avg
8.42%
3Y Avg
11.86%
5Y Avg
16.52%
Market Cap
$30.82B
Return on Equity (ROE)
83.10%
TTM Avg
66.19%
3Y Avg
56.82%
5Y Avg
52.60%
Market Cap
$30.64B
Return on Equity (ROE)
1.09%
TTM Avg
29.98%
3Y Avg
64.02%
5Y Avg
111.55%
Market Cap
$30.02B
Return on Equity (ROE)
14.51%
TTM Avg
21.84%
3Y Avg
21.53%
5Y Avg
32.27%
Market Cap
$34.20B
Return on Equity (ROE)
59.67%
TTM Avg
-187.43%
3Y Avg
134.89%
5Y Avg
51.69%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Centene Corp. (CNC) | $31.77B | -22.60% | -20.77% | -1.28% | 8.05% |
| DexCom, Inc. (DXCM)vs › | $31.88B | 38.14% | 28.93% | 25.01% | 22.95% |
| ResMed Inc. (RMD)vs › | $31.91B | 23.13% | 23.30% | 22.33% | 21.49% |
| Biogen Inc. (BIIB)vs › | $31.54B | 4.43% | 8.42% | 11.86% | 16.52% |
| Zoetis Inc. (ZTS)vs › | $30.82B | 83.10% | 66.19% | 56.82% | 52.60% |
| Waters Corporation (WAT)vs › | $30.64B | 1.09% | 29.98% | 64.02% | 111.55% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $30.02B | 14.51% | 21.84% | 21.53% | 32.27% |
| Alcon Inc. (ALC)vs › | $33.59B | 2.96% | 4.58% | 3.90% | 2.45% |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $34.20B | 59.67% | -187.43% | 134.89% | 51.69% |
| Medline Inc. (MDLN)vs › | $29.07B | 5.97% | 9.02% | 4.86% | 4.86% |
ROE
-22.6%
ROA
-6.1%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -22.60% |
| 2026-03-31 | -30.07% |
| 2025-12-31 | -33.44% |
| 2025-09-30 | -25.25% |
| 2025-06-30 | 7.49% |
| 2025-03-31 | 12.37% |
| 2024-12-31 | 12.51% |
| 2024-09-30 | 11.23% |
| 2024-06-30 | 10.32% |
| 2024-03-31 | 10.15% |
| 2023-12-31 | 10.46% |
| 2023-09-30 | 9.66% |
| 2023-06-30 | 10.57% |
| 2023-03-31 | 5.92% |
| 2022-12-31 | 5.00% |
| 2022-09-30 | 7.94% |
| 2022-06-30 | 7.08% |
| 2022-03-31 | 5.51% |
| 2021-12-31 | 5.03% |
| 2021-09-30 | 2.78% |
| 2021-06-30 | 2.78% |
| 2021-03-31 | 9.34% |
| 2020-12-31 | 7.02% |
| 2020-09-30 | 7.89% |
| 2020-06-30 | 6.21% |
| 2020-03-31 | 3.59% |
| 2019-12-31 | 10.53% |
| 2019-09-30 | 10.99% |
| 2019-06-30 | 10.51% |
| 2019-03-31 | 9.38% |
| 2018-12-31 | 8.24% |
| 2018-09-30 | 8.35% |
| 2018-06-30 | 10.13% |
| 2018-03-31 | 13.71% |
| 2017-12-31 | 12.09% |
| 2017-09-30 | 13.00% |
| 2017-06-30 | 12.62% |
| 2017-03-31 | 11.88% |
| 2016-12-31 | 9.60% |
| 2016-09-30 | 7.22% |
| 2016-06-30 | 6.47% |
| 2016-03-31 | 5.21% |
| 2015-12-31 | 16.46% |
| 2015-09-30 | 17.09% |
| 2015-06-30 | 17.50% |
| 2015-03-31 | 16.36% |
| 2014-12-31 | 15.51% |
| 2014-09-30 | 13.30% |
| 2014-06-30 | 12.51% |
| 2014-03-31 | 12.39% |
| 2013-12-31 | 13.38% |
| 2013-09-30 | 10.25% |
| 2013-06-30 | 6.74% |
| 2013-03-31 | 0.09% |
| 2012-12-31 | 0.20% |
| 2012-09-30 | 2.38% |
| 2012-06-30 | 5.05% |
| 2012-03-31 | 11.38% |
| 2011-12-31 | 11.89% |
| 2011-09-30 | 11.80% |
| 2011-06-30 | 11.54% |
| 2011-03-31 | 11.41% |
| 2010-12-31 | 11.94% |
| 2010-09-30 | 11.79% |
| 2010-06-30 | 12.02% |
| 2010-03-31 | 12.17% |
| 2009-12-31 | 13.93% |
| 2009-09-30 | 14.17% |
| 2009-06-30 | 14.36% |
| 2009-03-31 | 14.51% |
| 2008-12-31 | 16.66% |
| 2008-09-30 | 13.31% |
| 2008-06-30 | 13.32% |
| 2008-03-31 | 13.72% |
| 2007-12-31 | 17.69% |
| 2007-09-30 | 20.99% |
| 2007-06-30 | -0.35% |
| 2007-03-31 | -3.84% |
| 2006-12-31 | -13.37% |
| 2006-09-30 | -14.25% |
| 2006-06-30 | 10.61% |
| 2006-03-31 | 13.72% |
| 2005-12-31 | 15.80% |
| 2005-09-30 | 16.14% |
| 2005-06-30 | 16.64% |
| 2005-03-31 | 16.75% |
| 2004-12-31 | 16.33% |
| 2004-09-30 | 16.41% |
| 2004-06-30 | 16.25% |
| 2004-03-31 | 15.58% |
| 2003-12-31 | 15.11% |
| 2003-09-30 | 14.57% |
| 2003-06-30 | 26.27% |
